Company Filing History:
Years Active: 2016
Title: Tarmo Mölder: Innovator in Immunological Advances
Introduction
Tarmo Mölder, based in Tartu, Estonia, is a pioneering inventor with a focus on immunological advancements. He is known for his innovative work in the field of virology, particularly concerning the use of alphavirus replicase as an immunological adjuvant. His contributions aim to enhance vaccine efficacy and improve immune responses in various applications.
Latest Patents
Tarmo Mölder holds a patent for an "Expression vector encoding alphavirus replicase and the use thereof as an immunological adjuvant." This invention provides a method for utilizing an alphaviral replicase, specifically the Semliki Forest Virus replicase, which possesses RNA-dependent RNA polymerase activity. The invention's primary purpose is to use this replicase in combination with vaccines to enhance the immune response in subjects, resulting in a more robust defense compared to administering the vaccine alone. The goal of Tarmo's work is to create an efficient, easy-to-administer adjuvant that can be used across multiple species, offering significant improvements over existing adjuvants.
Career Highlights
Tarmo Mölder is associated with Fit Biotech Oy, where he collaborates on various projects aimed at developing innovative therapeutic solutions. His work reflects a commitment to enhancing medical technologies and improving public health outcomes through research and development.
Collaborations
In his professional journey, Tarmo has collaborated with notable colleagues such as Kaja Kiiver and Rein Sikut. These collaborations have allowed for a synergistic approach to addressing complex scientific challenges, leading to advancements in the field of immunology.
Conclusion
Tarmo Mölder's innovative work in the realm of immunity and vaccine adjuvants marks him as a significant contributor to the field. His patent demonstrates not only his inventive capabilities but also his dedication to improving healthcare through scientific research. As immunological challenges continue to evolve, the contributions of dedicated inventors like Tarmo will remain pivotal in shaping the future of medicine.